Configurationally stable analogs of styrylxanthines as A(2A) adenosine receptor antagonists

European Journal of Medicinal Chemistry

Volumn 32, Issue 9, 1997, Pages 709-719

  Muller C E ^a   Schobert, U ^a   Hipp, J ^a   Geis, U ^a   Frobenius, W ^a   Pawlowski, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

A(2A) adenosine receptor antagonist; Adenosine receptor; Bioactive conformation; E isomer; Styrylxanthine; Synthesis; Xanthine; Z isomer

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,7 DIMETHYL 1 PROPARGYLXANTHINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CYCLOHEXYLADENOSINE; RECEPTOR SUBTYPE; XANTHINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; DRUG CONFORMATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; RECEPTOR AFFINITY;

EID: 0343144807     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)88913-1     Document Type: Article

References (32)

1. Müller CE, Stein B (1996) Curr Pharm Des 2, 501-530
2. Fredholm B, Abbracchio MP, Burnstock G et al (1994) Pharm Rev 46, 143-156
3. Müller CE (1997) Exp Opin Ther Patents 7, 419-440
4. Schingnitz G, Küfner-Mühl U, Ensinger H, Lehr E, Kuhn FJ (1991) Nucleosides Nucleotides 10, 1067-1076
5. Kanda T, Shiozaki S, Shimada J, Suzuki F, Nakamura J (1994) Eur J Pharmacol 256, 263-268
6. Müller CE, Scior T (1993) Pharm Acta Helv 68, 77-111
7. Daly JW, Padgett WL, Shamim MT (1986) J Med Chem 29, 1305-1308
8. Seale TW, Abla KA, Shamim MT, Carney JM, Daly JW (1988) Life Sci 43, 1671-1684
9. Shamim MT, Ukena D, Padgett WL, Daly JW (1989) J Med Chem 32, 1231-1237
10. Erickson RH, Hiner RN, Feeney SW et al (1991) J Med Chem 34, 1431-1435
11. Shimada J, Suzuki F, Nonaka H, Ishii A, Ichikawa S (1992) J Med Chem 35, 2342-2345
12. Jacobson KA, Gallo-Rodriguez C, Melman N et al (1993) J Med Chem 36, 1333-1342
13. Müller CE et al (1996) Drug Dev Res 17, 112 (abstract)
14. Baraldi PG, Cacciari B, Spalluto G et al (1996) J Med Chem 39, 1164-1171
15. Poucher SM, Keddie JR, Singh P et al (1995) Br J Pharmacol 115, 1096-1102
16. Jackson EK, Herzer WA, Suzuki FJ (1993) Pharmacol Exp Ther 267, 1304-1310
17. Nonaka Y, Shimada J, Nonaka H et al (1993) J Med Chem 36, 3731-3733
18. Philip J, Szulczewski DH (1973) J Pharm Sci 62, 1885-1887
19. Müller CE (1993) Synthesis 125-128
20. Müller CE, Sandoval-Ramírez JA (1995) Synthesis 1295-1299
21. Müller CE, Shi D, Manning Jr M, Daly JW (1993) J Med Chem 36, 3341-3349
22. Grahner B, Winiwarter S, Lanzner W, Müller CE (1994) J Med Chem 37, 1526-1534
23. Van der Wenden EM, Van Galen PJM, Ijzerman AP, Soudijn W (1991) Eur J Pharmacol Mol Pharmacol 206, 315-323
24. Kirfel A, Schwabenländer F, Müller CE (1997) Zeitschrift für Kristallographie (CSD-No 402738) (in press)
25. Dooley MJ, Kono M, Suzuki F (1996) Bioorg Med Chem 4, 917-921
26. Bruns RF, Fergus JH (1989) J Pharm Pharmacol 41, 590-594
27. Müller CE (1991) Tetrahedron Lett 32, 6539-6540
28. Bruns RF, Daly JW, Snyder SH (1980) Proc Natl Acad Sci USA 77, 5547-5551
29. Bruns RF, Lu GH, Pugsley TA (1986) Mol Pharmacol 29, 331-346
30. Jacobson KA, Ukena D, Kirk KL, Daly JW (1986) Proc Natl Acad Sci USA 83, 4089-4093
31. Cheng YC, Prusoff WH (1973) Biochem Pharmacol 22, 3099-3108
32. Weissberger A, Taylor EC, eds (1972) The Chemistry of Heterocyclic Compounds. Indoles, Part I, Wiley Interscience, New York, Vol 25